- PROCRIT® (epoetin alpha) For the Treatment of Certain Types of Anemia
Learn more about PROCRIT® efficacy and safety, administration guidelines, dosing and support resources for the treatment of certain types of anemia
- PROCRIT® Information For Patients
Learn more about what PROCRIT® efficacy, side effects, risks, safety, and how it to can be a treatment for anemia
- What is PROCRIT
PROCRIT® is a prescription medicine the can be used as a treatment for anemia Learn more about efficacy, side effects, risks, and safety
- PROCRIT® Dosing for Chronic Kidney Disease (CKD)
Important dosing and administration guidelines for PROCRIT® use in treatment of anemia due to chronic kidney disease (CKD)
- PROCRIT® Dosing for Chemotherapy-Induced Anemia
PROCRIT ® is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy
- PROCRIT® Information for Health Care Professionals
Learn more about PROCRIT® efficacy and safety, administration guidelines, dosing and patient support resources
- PROCRIT® Efficacy and Safety: Chronic Kidney Disease
PROCRIT ® is indicated for the treatment of anemia due to CKD, including patients on dialysis and not on dialysis to decrease the need for red blood cell (RBC) transfusion
- Iron and PROCRIT® in Chronic Kidney Disease (CKD)
PROCRIT ® is indicated for the treatment of anemia due to chronic kidney disease (CKD), including patients on dialysis and not on dialysis, to decrease the need for red blood cell (RBC) transfusion
|